Pharmaceutical products for FDA/OPQ domestic manufacturing and regulatory purposes.

Ended Awarded Last action

Contract number
75F40123F19003
Awardee
Awarding agency
Obligated
$213,614

Award facts

Contract value 100% obligated
$213,614.19 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
PSC
Q999 Medical- Other
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Takoma Park, MD 20901, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Deobligation/closeout -$26,386
Original award $240,000

About this award

The Food and Drug Administration issued a $213,614.19 delivery order to We Pharma, Inc. on March 23, 2023, for pharmaceutical products supporting FDA domestic manufacturing and regulatory purposes.

Place of performance is Takoma Park, MD. The order carries a firm fixed price and ultimately closed on September 30, 2023. We Pharma, Inc. is a self-certified small disadvantaged business. The order was issued under no set-aside.

Quick answers

Who was awarded contract 75F40123F19003?

75F40123F19003 was awarded to We Pharma, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 23, 2023.

How much is contract 75F40123F19003 worth?

The government has obligated $213,614 on 75F40123F19003.

Is contract 75F40123F19003 an order under another contract?

Yes. 75F40123F19003 is a delivery order under 75F40121D00018, an indefinite delivery contract.

Was contract 75F40123F19003 competed?

The extent of competition for 75F40123F19003 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award